175 related articles for article (PubMed ID: 23442735)
1. Classification, morphology and molecular pathology of premalignant lesions of the pancreas.
Cooper CL; O'Toole SA; Kench JG
Pathology; 2013 Apr; 45(3):286-304. PubMed ID: 23442735
[TBL] [Abstract][Full Text] [Related]
2. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.
Basturk O; Hong SM; Wood LD; Adsay NV; Albores-Saavedra J; Biankin AV; Brosens LA; Fukushima N; Goggins M; Hruban RH; Kato Y; Klimstra DS; Klöppel G; Krasinskas A; Longnecker DS; Matthaei H; Offerhaus GJ; Shimizu M; Takaori K; Terris B; Yachida S; Esposito I; Furukawa T;
Am J Surg Pathol; 2015 Dec; 39(12):1730-41. PubMed ID: 26559377
[TBL] [Abstract][Full Text] [Related]
3. Premalignant cystic neoplasms of the pancreas.
Dudeja V; Allen PJ
Semin Oncol; 2015 Feb; 42(1):70-85. PubMed ID: 25726053
[TBL] [Abstract][Full Text] [Related]
4. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.
Singh M; Maitra A
Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961
[TBL] [Abstract][Full Text] [Related]
5. Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas.
Pittman ME; Rao R; Hruban RH
Arch Pathol Lab Med; 2017 Dec; 141(12):1606-1614. PubMed ID: 29189063
[TBL] [Abstract][Full Text] [Related]
6. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
[TBL] [Abstract][Full Text] [Related]
7. Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma?
Chidambaram S; Kawka M; Gall TM; Cunningham D; Jiao LR
Future Oncol; 2022 Jul; 18(23):2605-2612. PubMed ID: 35730473
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
Haugk B
Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
[TBL] [Abstract][Full Text] [Related]
9. Identification and analysis of precursors to invasive pancreatic cancer.
Matthaei H; Dal Molin M; Maitra A
Methods Mol Biol; 2013; 980():1-12. PubMed ID: 23359146
[TBL] [Abstract][Full Text] [Related]
10. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.
Fischer CG; Wood LD
J Pathol; 2018 Dec; 246(4):395-404. PubMed ID: 30105857
[TBL] [Abstract][Full Text] [Related]
11. Molecular biomarkers have the potential to improve the diagnostic work-up of pancreatic cystic lesions.
Plougmann JI; Klausen P; Karstensen JG; Vilmann P; Hasselby JP; Hansen CP; Kalaitzakis E
Scand J Gastroenterol; 2017 Sep; 52(9):932-940. PubMed ID: 28552018
[TBL] [Abstract][Full Text] [Related]
12. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].
Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F
Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019
[TBL] [Abstract][Full Text] [Related]
13. Current understanding of precursors to pancreatic cancer.
Takaori K
J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms: the interest of endoscopic ultrasonography.
Maire F; Couvelard A; Palazzo L; Aubert A; Vullierme MP; Rebours V; Hammel P; Sauvanet A; Levy P; Ruszniewski P
Pancreas; 2013 Nov; 42(8):1262-6. PubMed ID: 24152960
[TBL] [Abstract][Full Text] [Related]
15. [Precursors of Pancreatic cancer: Intraepithelial Neoplasia (PanIN) and Intraductal Papillary Mucinous Neoplasms (IPMN)].
Ledniczky G; Bognár G; Bereczky B; Barabás L; Ondrejka P
Magy Seb; 2009 Feb; 62(1):22-6. PubMed ID: 19218165
[TBL] [Abstract][Full Text] [Related]
16. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
[TBL] [Abstract][Full Text] [Related]
17. Precursor lesions in pancreatic cancer: morphological and molecular pathology.
Scarlett CJ; Salisbury EL; Biankin AV; Kench J
Pathology; 2011 Apr; 43(3):183-200. PubMed ID: 21436628
[TBL] [Abstract][Full Text] [Related]
18. Mucin expression profile in pancreatic cancer and the precursor lesions.
Nagata K; Horinouchi M; Saitou M; Higashi M; Nomoto M; Goto M; Yonezawa S
J Hepatobiliary Pancreat Surg; 2007; 14(3):243-54. PubMed ID: 17520199
[TBL] [Abstract][Full Text] [Related]
19. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.
Brune K; Abe T; Canto M; O'Malley L; Klein AP; Maitra A; Volkan Adsay N; Fishman EK; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Am J Surg Pathol; 2006 Sep; 30(9):1067-76. PubMed ID: 16931950
[TBL] [Abstract][Full Text] [Related]
20. [Precursors to pancreatic cancer].
Søreide K; Immervoll H; Molven A
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
